Skip to content

13F-HR filed by Blue Water Life Science Advisors, LP

Blue Water Life Science Advisors, LP filed this 13F-HR for the quarter ended 2023-09-30, filed 2023-11-14, with 7 holding rows worth $105,925,096.

Accession
0001172661-23-004050
Filed
2023-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2023

A holdings report, 7 entries on the cover page, a total value of $105,925,096 stated on the cover page (in dollars after the unit check, H1), rows summing to $105,925,096 with VALUE read as dollars as filed, 13F file number 028-20810. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
NATERA INC COM632307104Stock797,436$35,286,543dollars as filed
AKOYA BIOSCIENCES INC COM00974H104Stock4,697,785$21,844,700dollars as filed
GUARDANT HEALTH INC COM40131M109Stock676,047$20,038,033dollars as filed
ADAPTIVE BIOTECHNOLOGIES CORP COM00650F109Stock2,377,665$12,958,274dollars as filed
NANOSTRING TECHNOLOGIES INC63009R109COM3,751,891$6,453,253dollars as filed
MAXCYTE INC57777K106COM1,885,000$5,881,200dollars as filed
SONENDO INC835431107Common Stocks4,643,461$3,463,093dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001172661-23-004050this filing2023-11-14acceptance time not in the bulk data set